Sign in

CIK 0001815442 · Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812992166
Phone
857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
  1. 8-K Event Regulation FD disclosure · Other events
  2. 4 Insider Changes in Ownership
  3. 144 Insider Sale of Securities
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations · Regulation FD disclosure
  8. UPLOAD Other SEC-generated Letter
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. ARS Other Annual Report to Security Holders
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. UPLOAD Other SEC-generated Letter
  15. 4 Insider Changes in Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 12 of 33 · 647 filings